Roughly 33% of US adults report owning a gun, according to a 2021 Georgetown University firearms survey. By the end of 2022, New Frontier Data expects 4.7 million Americans to be registered medical cannabis cardholders.

How those two figures impact one another remains uncertain. But with federal laws preventing individuals from legally owning firearms while consuming Schedule I drugs, individuals using both could run into legal trouble.

Like much of U.S. cannabis law, state and federal rules don’t always align.

Click here to read the full article

About Bianchi & Brandt

Bianchi & Brandt offers a full suite of legal and strategic services tailored to the unique needs of complex industries, including cannabis and psychedelics, with a level of trust and expertise that is unmatched. With a deep bench of business law and regulatory specialists, the firm takes a holistic approach to client support across all operations. Bianchi & Brandt has served as a strategic partner to their clients and assisted not only with legal matters, but also risk management, compliance, M&A, and other business challenges. For over a decade, the firm has pursued its goal to help companies maximize results from founding through each new phase of growth. The Bianchi & Brandt team pride themselves on their long commitment to the industry and the deep client relationships forged by the firm’s founding partners. Learn more: bianchibrandt.com

Keep Reading

Laura Bianchi Featured in Exclusive Executive Interviews at Benzinga Cannabis Capital Conference

October 17, 2024

Laura Bianchi Featured in Benzinga Edge Exclusive “Cannabis Rescheduling Is Not Cure-All For Industry Problems: Experts Explain How Tax Tactics Could Hurt Marijuana Businesses In Long Run”

October 9, 2024

Bianchi & Brandt Nominated Second Year In a Row As Law Firm of the Year by Emjay Awards

October 1, 2024